TP53 and urinary bladder carcinoma: In contrast to RT4 (grade I; wild-type p53) that remained unaffected, T24 (grade III; mutant p53) bladder cancer cells presented with strong reduction of survival proficiency in response to 3-BrPA (Fig. 1a, b and d).